Results The overall efficacy rate of ziprasidone (64.29%) was higher than that of risperidone (42.85%).
结果齐拉西酮组总有效率为64.29%，明显高于利培酮组的42.85%。
OBJECTIVE: To study the pharmacokinetics of a single dose of intramuscularly injected ziprasidone mesylate in healthy volunteers.
目的：研究单剂量肌肉注射甲磺酸齐拉西酮后药动学。
After its approval by the US Food and Drug Administration, the second-generation antipsychotic, ziprasidone hydrochloride, was also included.
而且，自从第二代抗精神病药盐酸齐拉西酮获得美国食品药品监督局批准后，该药也被包括在内。
The incidence rate of adverse effect is 42.4% in Ziprasidone group and that is 57.6% in Aripiprazole group.
齐拉西酮组总不良反应发生率为42.4%，阿立哌唑组总不良反应发生率为57.6%。
Objective:To observe the prolactin level, amenorrhea and galactorrhea by Ziprasidone verse Risperidone in treatment of female schizophrenias providing reference for clinical use.
目的：观察女性精神病患者选用齐拉西酮片和利培酮片治疗前后催乳素水平的变化、溢乳及闭经情况，为临床用药提供参考。
Objective:To observe the prolactin level, amenorrhea and galactorrhea by Ziprasidone verse Risperidone in treatment of female schizophrenias providing reference for clinical use.
目的：观察女性精神病患者选用齐拉西酮片和利培酮片治疗前后催乳素水平的变化、溢乳及闭经情况，为临床用药提供参考。
应用推荐